Morgan Conn
Corporate Officer/Principal at PHARVARIS N.V.
Net worth: 6 M $ as of 30/04/2024
Network origin in Morgan Conn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 48 | |
| Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Morgan Conn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder Founder Director/Board Member Chairman Director/Board Member Founder Director/Board Member Founder | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact General Counsel Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal President Chief Tech/Sci/R&D Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer Investor Relations Contact Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Kosa Pharma GmbH | Founder Founder | ||
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale College | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
Newton-Wellesley Hospital Corp.
 Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Newton-Wellesley Hospital Corp. provides health care services. Its services include medical, surgical and diagnostic services. The company was founded in 1881 and is headquartered in Newton, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Doctorate Degree | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree Undergraduate Degree |
Statistics
International
| United States | 35 |
| Switzerland | 4 |
| Sweden | 4 |
| Netherlands | 3 |
| France | 3 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 14 |
| Finance | 7 |
| Health Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 435 |
| Corporate Officer/Principal | 188 |
| Independent Dir/Board Member | 136 |
| Chairman | 50 |
| President | 45 |
Most connected contacts
| Insiders | |
|---|---|
| Glenn Steele | 54 |
| Jerome Zeldis | 38 |
| Martijn Kleijwegt | 33 |
| Deepa Pakianathan | 32 |
| Carl Goldfischer | 31 |
| Richard H. Aldrich | 31 |
| Robert Spiegel | 30 |
| Rémi Droller | 29 |
| Michael Schmertzler | 28 |
| Adam Koppel | 26 |
| Peter Svennilson | 25 |
| Ronald Renaud | 24 |
| Axel Bolte | 23 |
| Berndt A. E. Modig | 23 |
| Johannes G. C. P. Schikan | 22 |
- Stock Market
- Insiders
- Morgan Conn
- Company connections
